Smith+Nephew Begins 2021 with Double-Digit Orthopedic Growth

Smith+Nephew's logo

Smith+Nephew reported 1Q21 orthopedic revenue of USD $897.9 million, +11% vs. 1Q20. While there is still significant geographic variability, the company said that procedure volumes are normalizing across more regions. Smith+Nephew sees the second half of the year as unconstrained by COVID restrictions.

Hip replacement continued to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us